FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1569487787> ?p ?o ?g. }

• W1569487787 endingPage "318" @default.
• W1569487787 startingPage "318" @default.
• W1569487787 abstract "INTRODUCTION Hysteroscopic surgeries, which require use of irrigating fluids like glycine can rarely be associated with significant complications.[12] We report a case of transient postoperative blindness following use of large quantities of glycine delivered through a rotatory pump set at an inappropriately high pressure. CASE REPORT A 27-year-old nulliparous female patient, American Society of Anesthesiologists grade I physical status with a history of menorrhagia and severe progressive dysmenorrhea, resistant to medical management, was scheduled for a hysteroscopic myomectomy under general anaesthesia, after ultrasound study revealed multiple submucous fibroids. Routine preoperative blood investigations were normal. Premedication included intramuscular glycopyrrolate 0.2 mg given half an hour before surgery, intravenous ranitidine 50 mg and intravenous ondansetron 4 mg. Anaesthesia was induced with intravenous thiopentone 250 mg, intravenous fentanyl 100 μg and intravenous atracurium 25 mg. After endotracheal intubation, 60% nitrous oxide in oxygen and isoflurane 0.8–1% was used for maintenance of anaesthesia with controlled ventilation. A 22F Karl Storz™ (Germany) resectoscope was used for hysteroscopy. To facilitate distension of the uterine cavity and better visualization during hysteroscopy, glycine 1.5% was infused at 200 mmHg pressure through the side port of Karl Storz endomat roller pump. 33 L glycine was infused and the outflow container collected 27 L. The procedure lasted for approximately 40 min. Haemodynamic parameters stayed within 20% of baseline values throughout the procedure. Neuromuscular blockade was reversed and the patient had an uneventful recovery from anaesthesia. On awakening, the patient complained of visual loss which was initially attributed to either residual effects of anaesthetic agents or the eye ointment. An hour after recovery in the postanaesthesia care unit (PACU), she was fully awake but complained of nausea, vomiting and had complete bilateral blindness. There were no other neurological deficits. On ophthalmic examination, the patient had normal eye movements, no light perception, mildly dilated pupils, normal intraocular pressures and absent direct and indirect light reflexes. Fundal examination revealed normal vasculature with no signs of the optic disc or macular oedema. A presumptive clinical diagnosis of glycine toxicity was made, and the patient was reassured that the blindness was a transient phenomenon. In the PACU, serum electrolytes, osmolality, urea, glucose, and ammonia were checked an hour after the procedure. Serum osmolality (282 mOsm/kg), serum potassium (4.3 mmol/L) and glucose were within normal limits. Serum ammonia was 137 μg/dl (reference range 27–102 μg/dl) and serum sodium was 127 mmol/L. Serum creatinine, liver function tests and blood urea nitrogen were within normal limits. 8 h after the procedure, serum ammonia was 234 μg/dl, serum sodium was 130 mmol/L and serum potassium was 2.3 mmol/L. Her vision showed signs of improvement and returned to normal within 20 h of the procedure. Serum ammonia level, checked 26 h after the procedure, was normal (52 μg/dl). Her remaining hospital stay was uneventful. She was discharged on the 3rd day after the surgery. DISCUSSION Glycine, a low-viscosity fluid, is favoured for uterine distension during hysteroscopies for its good optical image, poor electrical conduction, and minimal haemolysis.[3] Visual disturbances correlate with plasma glycine concentration of 5–8 mmol/L when glycine, an inhibitory neurotransmitter in the retina, slows down the transmission of impulses from the retina to the cerebral cortex resulting in prolonged visual evoked potentials and absent oscillatory potentials on the electroretinogram.[45] Transient blindness, which resolves within 24 h, following glycine absorption, has been reported.[6] Though blood ammonia (an intermediate product in glycine metabolism) concentration of more than 100 μmol/L (normal range 10–35) is associated with neurological symptoms,[7] inter-individual variability is great and patients may show neurological symptoms with normal blood ammonia concentration after absorbing large amounts of 1.5% glycine. There is a vague correlation between hyperammonaemia and visual disturbances.[8] There have been reports of transient blindness with high levels of ammonia after hysteroscopy, one case of temporary complete blindness, and several cases where visual acuity was temporarily reduced to perception of light after transurethral resection of prostate using glycine as the irrigation fluid.[9] In our patient, the increase in blood ammonia level corresponded with the period of blindness. For a better view, gynaecologists prefer a well-distended uterus. In our case, this was achieved by increasing the pressure (200 mmHg) to infuse glycine, which was higher than the safe standards suggested by Vulgaropulos et al.[10] (35–75 mmHg) which would have contributed to rapid absorption resulting in toxicity. CONCLUSION Large quantities of glycine, when used under higher than recommended pressures can result in excessive absorption and toxicity. With the increasing numbers of hysteroscopic procedures performed on a more routine basis, a more judicious use of irrigating solutions like glycine is necessary to avoid complications." @default.
• W1569487787 created "2016-06-24" @default.
• W1569487787 creator A5000054571 @default.
• W1569487787 creator A5002085105 @default.
• W1569487787 creator A5015308766 @default.
• W1569487787 creator A5064896497 @default.
• W1569487787 date "2015-01-01" @default.
• W1569487787 modified "2023-09-27" @default.
• W1569487787 title "Glycine induced acute transient postoperative visual loss" @default.
• W1569487787 cites W1971594264 @default.
• W1569487787 cites W1994118274 @default.
• W1569487787 cites W2002153558 @default.
• W1569487787 cites W2034313050 @default.
• W1569487787 cites W2048924393 @default.
• W1569487787 cites W2061948765 @default.
• W1569487787 cites W2151459548 @default.
• W1569487787 cites W41634617 @default.
• W1569487787 cites W68985319 @default.
• W1569487787 cites W70552109 @default.
• W1569487787 doi "https://doi.org/10.4103/0019-5049.156890" @default.
• W1569487787 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4445156" @default.
• W1569487787 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26019359" @default.
• W1569487787 hasPublicationYear "2015" @default.
• W1569487787 type Work @default.
• W1569487787 sameAs 1569487787 @default.
• W1569487787 citedByCount "8" @default.
• W1569487787 countsByYear W15694877872015 @default.
• W1569487787 countsByYear W15694877872018 @default.
• W1569487787 countsByYear W15694877872019 @default.
• W1569487787 countsByYear W15694877872020 @default.
• W1569487787 countsByYear W15694877872021 @default.
• W1569487787 crossrefType "journal-article" @default.
• W1569487787 hasAuthorship W1569487787A5000054571 @default.
• W1569487787 hasAuthorship W1569487787A5002085105 @default.
• W1569487787 hasAuthorship W1569487787A5015308766 @default.
• W1569487787 hasAuthorship W1569487787A5064896497 @default.
• W1569487787 hasBestOaLocation W15694877871 @default.
• W1569487787 hasConcept C141071460 @default.
• W1569487787 hasConcept C2776277131 @default.
• W1569487787 hasConcept C2776359302 @default.
• W1569487787 hasConcept C2776814716 @default.
• W1569487787 hasConcept C2778300832 @default.
• W1569487787 hasConcept C2781072394 @default.
• W1569487787 hasConcept C42219234 @default.
• W1569487787 hasConcept C71924100 @default.
• W1569487787 hasConceptScore W1569487787C141071460 @default.
• W1569487787 hasConceptScore W1569487787C2776277131 @default.
• W1569487787 hasConceptScore W1569487787C2776359302 @default.
• W1569487787 hasConceptScore W1569487787C2776814716 @default.
• W1569487787 hasConceptScore W1569487787C2778300832 @default.
• W1569487787 hasConceptScore W1569487787C2781072394 @default.
• W1569487787 hasConceptScore W1569487787C42219234 @default.
• W1569487787 hasConceptScore W1569487787C71924100 @default.
• W1569487787 hasIssue "5" @default.
• W1569487787 hasLocation W15694877871 @default.
• W1569487787 hasLocation W15694877872 @default.
• W1569487787 hasLocation W15694877873 @default.
• W1569487787 hasLocation W15694877874 @default.
• W1569487787 hasOpenAccess W1569487787 @default.
• W1569487787 hasPrimaryLocation W15694877871 @default.
• W1569487787 hasRelatedWork W2001683931 @default.
• W1569487787 hasRelatedWork W2347911360 @default.
• W1569487787 hasRelatedWork W2361468386 @default.
• W1569487787 hasRelatedWork W2367927558 @default.
• W1569487787 hasRelatedWork W2418368419 @default.
• W1569487787 hasRelatedWork W2419357890 @default.
• W1569487787 hasRelatedWork W2474101975 @default.
• W1569487787 hasRelatedWork W4248434566 @default.
• W1569487787 hasRelatedWork W4285091663 @default.
• W1569487787 hasRelatedWork W56975623 @default.
• W1569487787 hasVolume "59" @default.
• W1569487787 isParatext "false" @default.
• W1569487787 isRetracted "false" @default.
• W1569487787 magId "1569487787" @default.
• W1569487787 workType "article" @default.